English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/10527
Compartir / Impacto:
Estadísticas
Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Título

LC-based analysis of drugs of abuse and their metabolites in urine

AutorPizzolato, Tânia Mara; López de Alda, Miren; Barceló, Damià
Palabras claveAnalysis
Cocaine
Drug of abuse
LC-MS2
Liquid chromatography
Mass spectrometry
Urine
Water
Fecha de publicación24-abr-2007
EditorElsevier
CitaciónTrAC-Trends in Analytical Chemistry 26(6): 609-624 (2007)
ResumenIn the literature, many analytical methods have been described for the determination of illicit drugs in biological fluids. Urine is one of the preferred matrices for control of drugs of abuse because its analysis is considered non-invasive and the concentration of the compounds and their metabolites, as well as the volume of sample available, are higher than in other biological fluids. For the analysis of drugs of abuse in urine, liquid chromatography coupled to mass spectrometry (LC-MS) or tandem mass spectrometry (LCMS2) has become a powerful technique. Its main advantages are its selectivity and sensitivity, reduced need for sample preparation, absence of need for derivatization and reliability of results. In addition, when two selected reaction monitoring (SRM) transitions are recorded per compound, this technique provides the four identification points required by the European Union for identification and confirmation of illicit substances. For preconcentration or clean up of samples, specific procedures, such as those using mixed-mode solid phases, have allowed good recoveries and low limits of detection, and helped reduce ion suppression in LC-MS2. This review discusses methods published in 2000–2006 to determine the drugs of abuse consumed most (namely, amphetamines, methamphetamines, cannabinoids, cocaine, LSD and opiates) and their metabolites in urine, particularly by LC-MS2.
Descripción16 pages, 6 figures, 2 tables.-- Printed version published Jun 2007.-- Issue title: Pharmaceutical-residue analysis.
Versión del editorhttp://dx.doi.org/10.1016/j.trac.2007.04.005
URIhttp://hdl.handle.net/10261/10527
DOI10.1016/j.trac.2007.04.005
ISSN0167-2940
Aparece en las colecciones: (IDAEA) Artículos
Ficheros en este ítem:
No hay ficheros asociados a este ítem.
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.